The PUMA Trial is a Trial of a Single ProHema Modulated-CB Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies.
This study has been terminated.
Information provided by (Responsible Party):
First received: June 21, 2012
Last updated: June 22, 2017
Last verified: June 2017
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Study Completion Date:||February 2017|
|Primary Completion Date:||July 2016 (Final data collection date for primary outcome measure)|